Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Irrus Investments
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Irrus Investments Similar startupsby what they do, their industry and backers
Sweetch empowers B2B2C partners like Abbott, Dexcom, NovoCare with AI-driven CGM support for Blood Sugar, Type 2 Diabetes management…
Award-winning digital therapeutic programs for diabetes care and weight loss trusted by doctors. 15K+ people have prevented, managed and…
Network Bio builds AI on the world's largest patient tissue training dataset, linked to blood samples and clinical outcomes from top US…
ZOE is a London health science company founded in 2017 that personalises nutrition advice from individual biological responses. Its at-home…
The CUE1 and CUE1+ by Charco Neurotech offers a novel, non-invasive approach to increasing quality of life for people with Parkinson's.
Our next-generation health monitor unlocks an ongoing dialogue between you and your body. Similar to blood, saliva can be used to track…
Overview
A Groundbreaking, Non-Pharmaceutical Approach to Blood Sugar and Weight Management. Sigrid Therapeutics is pioneering a non-pharmaceutical approach to blood sugar control and weight management.
News
Sigrid Therapeutics Secures U.S. Market Access for SiPore Technology Following SHINE Prediabetes Study Success
Sigrid Therapeutics (Sigrid) is excited to announce that it has secured U.S. market access for its proprietary SiPore technology, following the success of the SHINE study, the largest of its kind in prediabetes.
Read more
Report